Alaska Becomes Latest State To Regulate PBMs
Inside Health Policy
This week Alaska became the latest state to require pharmacy benefit managers be licensed…Read More.
SCPC Praises House Energy and Commerce Leaders’ Ongoing Query of PBM Drug Pricing Role
National LTC Pharmacy Group Thanks Reps. Greg Walden, Michael Burgess and Greg Harper for Issuing New Letters to Nation’s Pharmacy Benefit Managers (PBMs)…Read More.
Delaware Makes Drug Prices More Transparent
Delaware Public Radio
A new law eliminates the so-called gag clause making it easier for pharmacists to tell patients in Delaware about the lowest prices for their prescriptions…Read More.
Consumer Advocates Urge State Insurance Regulators To Use Authority To Fight High Drug Prices
Inside Health Policy
Two consumer advocates recently urged state insurance regulations to weigh using their administrative power — including rate review authority — to control rising drug costs and improve transparency, even if state legislators are unable to push through changes…Read More.
PBMs Are Hogging Our Drug Discounts
The Trump administration has aimed a dagger at the heart of high pharmacy bills: the go-betweens in the supply chain that have been gouging insurers, drugmakers, and, most importantly, consumers…Read More.
To Help Seniors Served by LTC Pharmacies, DIR Fees Should Simply be Prohibited
Tired of being kept in the dark about the mysterious prescription drug cost pricing process, Congress has proposed a variety of bipartisan legislative reforms designed to shed light on a system seemingly designed at the outset to confuse, befuddle and bewilder…Read More.
Grassley Praised by National LTC Pharmacy Group for Seeking Justice Department Review of PDP/PBM Mergers
SCPC praised Senate Judiciary Committee Chairman Charles Grassley (R-IA) for asking the U.S. Justice Department to conduct a “robust analysis” of the proposed mergers between CVS Health and Aetna, and Cigna Corp. and Express Scripts…Read More.
Walden, Burgess request federal merger review of Pharmacy Benefit Managers
The Ripon Advance
U.S. Reps. Greg Walden (R-OR) and Michael Burgess (R-TX) want details about whether the mega-mergers among Pharmacy Benefit Managers (PBMs) has contributed to rising national drug prices for the more than 266 million Americans using PBM prescription drug plans…Read More.
Transparent pharmacy benefits: a path to rational drug costs
Now that states are moving to block pharmacy benefit managers from imposing “gag orders” on pharmacists, industry insiders and policymakers are sounding off louder than ever about the tendency for pharmacy benefit managers to extract value from the health system rather than add value to it…Read More.